v3.25.2
NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Feb. 13, 2025
Jan. 22, 2025
Dec. 31, 2024
Dec. 30, 2024
Oct. 02, 2024
Sep. 27, 2024
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Aspire Biopharma Inc [Member]                  
Debt interest rate     20.00% 20.00% 20.00% 20.00%      
Principal amount     $ 279,878 $ 40,625 $ 62,500 $ 1,066,391      
Gross proceeds     $ 2,500,000 $ 2,500,000 $ 2,500,000 $ 2,500,000      
Debt interest stated percentage     5.00% 5.00% 5.00% 5.00%      
Debt unamortized discount     $ 46,646 $ 8,125 $ 12,500 $ 213,278      
Parent Company [Member]                  
Debt interest rate 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%      
Principal amount $ 31,250 $ 31,250 $ 279,878 $ 40,625 $ 62,500 $ 1,066,391      
Gross proceeds $ 2,500,000 $ 2,500,000 $ 2,500,000 $ 2,500,000 $ 2,500,000 $ 2,500,000   $ 257,645
Debt interest stated percentage 5.00% 5.00% 5.00% 5.00% 5.00% 5.00%      
Debt unamortized discount $ 6,250 $ 6,250 $ 46,646 $ 8,125 $ 12,500 $ 213,278      
Parent Company [Member] | September Twenty Seven Two Thousand Twenty Four [Member]                  
Amortized debt discount             $ 68,733 139,052  
Parent Company [Member] | October Two Two Thousand Twenty Four [Member]                  
Amortized debt discount             4,121 8,379  
Parent Company [Member] | December Thirty Two Thousand Twenty Four [Member]                  
Amortized debt discount             2,709 5,388  
Parent Company [Member] | December Thirty First Two Thousand Twenty Four [Member]                  
Amortized debt discount             15,550 27,170  
Parent Company [Member] | January Twenty Two Two Thousand Twenty Five [Member]                  
Amortized debt discount             2,084 3,641  
Parent Company [Member] | February Thirteen Two Thousand Twenty Five [Member]                  
Amortized debt discount             $ 2,084 $ 3,137